Assessing the Efficacy of Telemedicine for Managing Chronic Illnesses in Younger Adults with Type 2 Diabetes

Telemedicine is transforming chronic disease management, particularly for younger adults with Type 2 Diabetes. This investigation evaluates its efficacy in improving glycemic control, adherence, and lifestyle changes compared to traditional care. To assess the effectiveness of telemedicine for managing Type 2 Diabetes in younger adults by evaluating health outcomes, patient engagement, and satisfaction. Data from 200 participants' intervention and control is collected at four periods (Baseline, 3, 6, and 12 months); data collection can be conducted via surveys. Key variables include HbA1c levels, medication adherence, patient engagement score, lifestyle changes score, and satisfaction with care. These variables assess the impact of telemedicine on diabetes management compared to standard in-person healthcare approaches. Using IBM SPSS 26, paired t-tests analyze intra-group HbA1c changes, ANOVA compares multi-period variations, and logistic regression determines adherence predictors. Preliminary findings suggested that telemedicine improves HbA1c levels, engagement, and adherence, though lifestyle changes vary significantly across participants. Telemedicine effectively improved diabetes management outcomes, showing significant gains in HbA1c reduction (88%), medication adherence (85%), and patient engagement (82%). Findings support telemedicine as a viable alternative to in-person care, though further analyses should explore long-term impacts and scalability challenges.